Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets

Area of Science:

• Economics
• Intellectual Property Law
• Pharmaceutical Industry Analysis

Background:

• Traditional intellectual property analysis balances research incentives against welfare costs of reduced price competition.
• Patents, while restricting price competition, can also stimulate non-price competition, specifically marketing efforts.

Purpose of the Study:

• To theoretically and empirically investigate the static welfare effects of marketing incentives provided by intellectual property.
• To analyze how marketing efforts influence consumer welfare in the context of pharmaceutical patents.

Main Methods:

• Theoretical modeling of marketing incentives and their impact on static welfare.
• Empirical analysis using data from the pharmaceutical industry to assess short-run and long-run effects of patent expirations.

Main Results:

• Stronger marketing incentives can mitigate or even offset the static welfare costs associated with monopoly pricing.
• In the short run, patent expirations in pharmaceuticals can decrease consumer welfare due to reduced marketing.
• Long-run consumer benefits from patent expirations are approximately 30% less than price reductions alone would suggest.

Conclusions:

• The social value of monopoly marketing to consumers is comparable to its costs for firms.
• A nuanced understanding of intellectual property's impact requires considering non-price competition, such as marketing.
• Policy implications suggest that the welfare effects of patents are more complex than traditional price-competition models indicate.